Our Scientific Advisory Panel brings together a diverse range of scientific expertise and knowledge. The panel helps drive forward our strategic vision of funding novel non-animal medical methodologies that are human-relevant, robust and remove animals from research laboratories for good.
Professor Martin Clift
Martin is an Associate Professor at Swansea University Medical School and current chair of the UK In Vitro Toxicology Society. His research focus is upon developing advanced in vitro lung models of both the upper and lower airways. He further utilises these systems to deduce the mechanistic toxicological and immunological implications of inhalation exposure to (nano)particles and fibres. He is also Editor-in-Chief of Fibres, Associate Editor of the Journal of Nanobiotechnology and an Editorial Board member for a number of journals within his field.
“The opportunity to work with Animal Free Research UK is a fantastic one! Not only do I get to help ongoing and future advantageous alternative approaches towards animal experiments, but to support early career researchers progress within this exciting, constantly expanding field of research.”
Professor Lorna Harries
Lorna holds a personal Chair in Molecular Genetics at the University of Exeter College of Medicine and Health. She has interests in the regulation of gene expression and how this impacts human diseases such as type 2 diabetes and other age-related disorders.
“I am delighted to work with Animal Free Research UK to ensure that we fund cutting edge research of direct relevance to human diseases, which can be more readily translated to the clinic.”
Dr Dania Movia
Dania is a Senior Research Fellow at the Trinity Translational Medicine Institute of Trinity College Dublin, Ireland’s leading university. She also lectures in the molecular medicine MSc at the School of Medicine. Dania was awarded an MSc in Chemistry and Pharmaceutical Technologies at University of Trieste (Italy) in 2007 and a PhD in Chemistry at Trinity College Dublin in 2012.
As principal investigator for a grant funded by the John Hopkins’ Center for Alternatives to Animal Testing, co-principal investigator in the EU Horizon 2020 Biomaterial Risk Management (BIORIMA) project and reviewer for the European Innovation Council, she is an EU expert in cancer and alternatives to animal research.
“It is about time we stop curing cancer in animals, and we start finding how to do it in humans. Animal Free Research UK is a charity that supports shaping a world where human-relevant basic research is possible. Being a member of its Scientific Advisory Panel means that now I will be able to facilitate young scientists that would like to pursue animal free research in their career.”
Professor Mike Philpott (Chair)
Mike has over 30 years of research experience in developing human models of disease. During his PhD he created the first method to successfully isolate and grow human hair follicles in the laboratory – now widely known as the ‘Philpott model’. He continues to champion human models of disease as Professor of Cutaneous Biology and Head of the Animal Free Research UK Animal Replacement Centre at Queen Mary University of London.
“As someone who is strongly committed to developing animal free models of human disease, I strongly support the goals of Animal Free Research UK and am delighted to be working with them as Chair of their Scientific Advisory Panel.”
Dr Malcolm Wilkinson
Malcolm studied Physics at Oxford but is now a specialist in medical and biomedical devices and CEO of Kirkstall Ltd. He is co-author on several papers on in-vitro models of toxicity and a contributing editor of a recently published book on In-Vitro Testing. He is a champion for the use of leading-edge technology to replace animal testing for the development of safe drugs, nutraceuticals, chemicals and cosmetics.
“I am delighted to be part of the Animal Free Research UK Scientific Advisory Panel. There are outstanding scientific and ethical reasons to move to animal free research. We need to reduce the time and money we put into misleading animal models of disease and focus on human based biology.”
Page last modified on May 16, 2022 1:29 pm